Results 231 to 240 of about 2,915,603 (326)

15 Years of Intermittent Therapy With Hydroxychloroquine Without Any Loss of Efficacy in Reticular Erythematous Mucinosis. [PDF]

Case Rep Dermatol Med
Di Giuli N, Bonelli A, Volonté M, Isoletta E, Brazzelli V.   +4 more
europepmc   +1 more source

Tremor as an intrinsic feature of juvenile myoclonic epilepsy

Epilepsia, Volume 66, Issue 3, Page e47-e53, March 2025.
Abstract We aim to understand whether tremor may be an intrinsic feature of juvenile myoclonic epilepsy (JME) and whether individuals with JME plus tremor experience a different disease course. Thirty‐one individuals with JME plus tremor (17 females, mean age = 33.9 ± 13.8 years) and 30 age of onset‐ and gender‐matched subjects with JME (21 females ...
Alessia Giugno, Francesco Fortunato, Ilaria Sammarra, Miriam Sturniolo, Enrico Fratto, Iolanda Martino, Rita Nisticò, Antonio Gambardella   +7 more
wiley   +1 more source

The human photosensitive epilepsy model for clinical proof‐of‐principle trials of novel antiseizure medications: 2. Analysis of drug trials and predictive value of the model

Epilepsia, EarlyView.
Abstract Clinical development of novel antiseizure medications (ASMs) would benefit from an early proof of principle (POP) model. The photosensitivity model, which uses the photoparoxysmal electroencephalographic response (PPR) as a surrogate of seizures, is currently the only human model that allows POP trials of investigational compounds after a ...
Wolfgang Löscher, Dorothée Kasteleijn‐Nolst Trenité   +1 more
wiley   +1 more source

Adult Phenotype of CHD2-Associated Disorders. [PDF]

Neurol Genet
Rong M, Zulfiqar Ali Q, Aledo-Serrano A, Bayat A, Devinsky O, Qaiser F, Chandran I, Ali A, Fasano A, Bassett AS, Andrade DM.   +10 more
europepmc   +1 more source

The human photosensitive epilepsy model for clinical proof‐of‐principle trials of novel antiseizure medications. 1. Use of the EEG in drug development and characteristics of the model

Epilepsia, EarlyView.
Abstract Clinical development of novel antiseizure medications (ASMs) would benefit from an early proof‐of‐principle (POP) model. The photosensitivity model, which uses the photoparoxysmal electroencephalography (EEG) response (PPR) as a surrogate for seizures, is currently the only human model that allows POP trials of investigational compounds after ...
Dorothée Kasteleijn‐Nolst Trenité, Wolfgang Löscher   +1 more
wiley   +1 more source

Hepatoerythropoietic Porphyria with Coexisting <i>BTD</i> And <i>CNGB1</i> Genetic Mutations: A First Case Report. [PDF]

Eur J Case Rep Intern Med
Kaya Ç, Heydari A, Kızılay O, Kızılay O, Sezgin G.   +4 more
europepmc   +1 more source

The unseen in COVID-19. [PDF]

Indian J Ophthalmol
Bassi ST, Bassi M.
europepmc   +1 more source

Seizure forecasting by tracking cortical response to electrical stimulation

Epilepsia, EarlyView.
Abstract Objective Seizure unpredictability is a significant burden in the lives of people with epilepsy. Previously published approaches to seizure forecasting analyzed intracranial electroencephalography (iEEG) recordings and showed that seizures can be forecast above chance levels.
Petroula Laiou, Zeljko Kraljevic, Antonio Valentin, Sharon Jewell, Pedro F. Viana, Chirag Mehra, Richard J. B. Dobson, Andreas Schulze‐Bonhage, Matthias Dümpelmann, Timothy J. Denison, Joel S. Winston, Mark P. Richardson   +11 more
wiley   +1 more source

Golimumab-Induced Anti-NuMA-1 (Nuclear Mitotic Apparatus Protein 1) Antibodies in a Rheumatoid Arthritis Patient: A Case Report. [PDF]

Cureus
Bensaghir I, Tahiri L, Taoufik Y, Rkain H, Allali F.   +4 more
europepmc   +1 more source

Visual cortex hyperexcitability contributes to the pathophysiology of the photoparoxysmal response [PDF]

, 2016
Rocchi, L, Suppa, A
core